422
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Insightful exploring of advanced nanocarriers for the topical/transdermal treatment of skin diseases

& ORCID Icon
Pages 1136-1157 | Received 02 Sep 2020, Accepted 07 Nov 2021, Published online: 18 Nov 2021

References

  • Abd E, Namjoshi S, Mohammed YH, Roberts MS, Grice JE. 2016. Synergistic skin penetration enhancer and nanoemulsion formulations promote the human epidermal permeation of caffeine and naproxen. J Pharm Sci. 105(1):212–220.
  • Abdel Motaal A, Ali MA, El-Gazayerly ON. 2016. An in vivo study of hypericum perforatum in topical drug delivery systems. Planta Med. 81(S01):S1–S381.
  • Abdelgawad R, Nasr M, Moftah NH, Hamza MY. 2017. Phospholipid membrane tubulation using ceramide doping “Cerosomes”: characterization and clinical application in psoriasis treatment. Eur J Pharm Sci. 101:258–268.
  • AbdelSamie S, Kamel A, Sammour O, Ibrahim S. 2016. Terbinafine hydrochloride nanovesicular gel: in vitro characterization, ex vivo permeation and clinical investigation. Eur J Pharm Sci. 88:91–100.
  • Abdulbaqi I, Darwis Y, Assi R, Khan N. 2018. Transethosomal gels as carriers for the transdermal delivery of colchicine: statistical optimization, characterization, and ex vivo evaluation. Drug Des Devel Ther. 12:795–813.
  • Abu-Azzam O, Nasr M. 2020. In vitro anti-inflammatory potential of phloretin microemulsion as a new formulation for prospective treatment of vaginitis. Pharm Dev Technol. 13:1–6.
  • Aggarwal N, Goindi S. 2012. Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of microsporum canis-dermatophytosis. Int J Pharm. 437(1–2):277–287.
  • Agiba AM, Nasr M, Abdel-Hamid S, Eldin AB, Geneidi AS. 2018. Enhancing the intestinal permeation of the chondroprotective nutraceuticals glucosamine sulphate and chondroitin sulphate using conventional and modified liposomes. Curr Drug Deliv. 15(6):907–916.
  • Agrawal Y, Petkar KC, Sawant KK. 2010. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm. 401(1–2):93–102.
  • Ahad A, Raish M, Al-Mohizea A, Al-Jenoobi F, Alam M. 2014. Enhanced anti-inflammatory activity of carbopol loaded meloxicam nanoethosomes gel. Int J Biol Macromol. 67:99–104.
  • Ainbinder D, Touitou E. 2005. Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv. 12(5):297–303.
  • Aldalaen S, Nasr M, El-Gogary RI. 2020. Angiogenesis and collagen promoting nutraceutical-loaded nanovesicles for wound healing. J Drug Deliv Sci Technol. 56:101548.
  • Ali J, Akhtar N, Sultana Y, Baboota S, Ahuja A. 2008. Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia). Methods Find Exp Clin Pharmacol. 30(4):277–285.
  • Ali MF, Salah M, Rafea M, Saleh N. 2008. Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting. Med Sci Monit. 14(12):PI66–74.
  • Allen TM. 1997. Liposomes. Opportunities in drug delivery. Drugs. 54(4):8–14.
  • Alomrani AH, Shazly GA, Amara AA, Badran MM. 2014. Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model. Colloid Surf B Biointerfaces. 121:74–81.
  • Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM. 2005. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm. 59(3):485–490.
  • Amer SS, Nasr M, Abdel-Aziz RTA, Moftah NH, El Shaer A, Polycarpou E, Mamdouh W, Sammour O. 2020. Cosm-nutraceutical nanovesicles for acne treatment: physicochemical characterization and exploratory clinical experimentation. Int J Pharm. 577:119092.
  • Amer SS, Nasr M, Mamdouh W, Sammour O. 2019. Insights on the use of nanocarriers for acne alleviation. Curr Drug Deliv. 16(1):18–25.
  • Amnuaikit T, Limsuwan T, Khongkow P, Boonme P. 2018. Vesicular carriers containing phenylethyl resorcinol for topical delivery system; liposomes, transfersomes and invasomes. Asian J Pharm Sci. 13(5):472–484.
  • Arafa MG, Ayoub BM. 2017. DOE optimization of nano-based carrier of pregabalin as hydrogel: new therapeutic & chemometric approaches for controlled drug delivery systems. Sci Rep. 7:41503.
  • Ascenso A, Raposo S, Batista C, Cardoso P, Mendes T, Praça F, Bentley M, Simões S. 2015. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes. Int J Nanomedicine. 10:5837–5851.
  • Asthana GS, Asthana A, Singh D, Sharma PK. 2016. Etodolac containing topical niosomal gel: formulation development and evaluation. J Drug Deliv. 2016:9324567.
  • Avadhani K, Manikkath J, Tiwari M, Chandrasekhar M, Godavarthi A, Vidya S, Hariharapura R, Kalthur G, Udupa N, Mutalik S. 2017. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage. Drug Deliv. 24(1):61–74.
  • Awan ZA, A. Fahmy U, Badr-Eldin SM, Ibrahim TS, Asfour HZ, Al-Rabia MW, Alfarsi A, Alhakamy NA, Abdulaal WH, Al Sadoun H, et al. 2020. The enhanced cytotoxic and pro-apoptotic effects of optimized simvastatin-loaded emulsomes on MCF-7 breast cancer cells. Pharmaceutics. 12(7):597.
  • Bangham AD, Standish MM, Watkins JC. 1965. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 13(1):238–252.
  • Barakat SS, Nasr M, Ahmed RF, Badawy SS, Mansour S. 2017. Intranasally administered in situ gelling nanocomposite system of dimenhydrinate: preparation, characterization and pharmacodynamic applicability in chemotherapy induced emesis model. Sci Rep. 7(1):9910.
  • Barradas TN, Senna JP, Cardoso SA, Nicoli S, Padula C, Santi P, Rossi F, de Holanda E Silva KG, Mansur CR. 2017. Hydrogel-thickened nanoemulsions based on essential oils for topical delivery of psoralen: permeation and stability studies. Eur J Pharm Biopharm. 116:38–50.
  • Bavarsad N, Akhgari A, Seifmanesh S, Salimi A, Rezaie A. 2016. Statistical optimization of tretinoin-loaded penetration-enhancer vesicles (PEV) for topical delivery. Daru. 24:1–12.
  • Betz G, Imboden R, Imanidis G. 2001. Interaction of liposome formulations with human skin in vitro. Int J Pharm. 229(1–2):117–129.
  • Bhalekar M, Upadhaya P, Madgulkar A. 2015. Formulation and evaluation of adapalene-loaded nanoparticulates for epidermal localization. Drug Deliv Transl Res. 5(6):585–595.
  • Bhalekar MR, Pokharkar V, Madgulkar A, Patil N, Nilkanth P. 2009. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech. 10(1):289–296.
  • Bharadwaj R, Das PJ, Pal P, Mazumder B. 2016. Topical delivery of paclitaxel for treatment of skin cancer. Drug Dev Ind Pharm. 42(9):1482–1494.
  • Bhatia A, Kumar R, Katare OP. 2004. Tamoxifen in topical liposomes: development, characterization and in vitro evaluation. J Pharm Pharm Sci. 7(2):252–259.
  • Bhatia G, Zhou Y, Banga AK. 2013. Adapalene microemulsion for transfollicular drug delivery. J Pharm Sci. 102(8):2622–2631.
  • Bhavsar B, Choksi B, Sanmukhani J, Dogra A, Haq R, Mehta S, Mukherjee S, Subramanian V, Sheikh S, Mittal R. 2014. Clindamycin 1% nanoemulsion gel formulation for the treatment of acne vulgaris: results of a randomized, active controlled, multicentre, phase IV clinical trial. J Clin Diagn Res. 8:YC05–09.
  • Bozzuto G, Molinari A. 2015. Liposomes as nanomedical devices. Int J Nanomedicine. 10:975–999.
  • Bseiso EA, Nasr M, Sammour O, Abd El Gawad NA. 2015. Recent advances in topical formulation carriers of antifungal agents. Indian J Dermatol Venereol Leprol. 81(5):457–463.
  • Bsieso E, Nasr M, Moftah N, Sammour O, Abd El Gawad N. 2015. Could nanovesicles containing a penetration enhancer clinically improve the therapeutic outcome in skin fungal diseases? Nanomedicine (Lond). 10(13):2017–2031.
  • Bsieso E, Nasr M, Moftah N, Sammour O, Abd El Gawad N. 2016. Novel nail penetration enhancer containing vesicles “nPEVs” for treatment of onychomycosis. Drug Deliv. 23(8):2813–2819.
  • Budhiraja A, Dhingra G. 2015. Development and characterization of a novel antiacne niosomal gel of rosmarinic acid. Drug Deliv. 22(6):723–730.
  • Burchacka E, Potaczek P, Paduszyński P, Karłowicz-Bodalska K, Han T, Han S. 2016. New effective azelaic acid liposomal gel formulation of enhanced pharmaceutical bioavailability. Biomed Pharmacother. 83:771–775.
  • Caddeo C, Manca M, Peris J, Usach I, Diez-Sales O, Matos M, Fernàndez-Busquets X, Fadda A, Manconi M. 2018. Tocopherol-loaded transfersomes: in vitro antioxidant activity and efficacy in skin regeneration. Int J Pharm. 551(1–2):34–41.
  • Caddeo C, Manconi M, Sinico C, Valenti D, Celia C, Monduzzi M, Fadda A. 2015. Penetration enhancer-containing vesicles: does the penetration enhancer structure affect topical drug delivery? Curr Drug Targets. 16(13):1438–1447.
  • Cadena PG, Pereira MA, Cordeiro RBS, Cavalcanti IMF, Barros Neto B, Pimentel MDCCB, Lima Filho JL, Silva VL, Santos-Magalhães NS. 2013. Nanoencapsulation of quercetin and resveratrol into elastic liposomes. Biochim Biophys Acta. 1828(2):309–316.
  • Cereda C, Franz-Montan M, Da Silva C, Casadei B, Domingues C, Tofoli G, De Araujo D, De Paula E. 2013. Transdermal delivery of butamben using elastic and conventional liposomes. J Liposome Res. 23(3):228–234.
  • Cereda CM, Guilherme VA, Alkschbirs MI, de Brito Junior RB, Tofoli GR, Franz-Montan M, de Araujo DR, de Paula E. 2017. Liposomal butamben gel formulations: toxicity assays and topical anesthesia in an animal model. J Liposome Res. 27(1):74–82.
  • Cevc G, Blume G. 1992. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1104(1):226–232.
  • Cevc G, Blume G. 2003. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes. Biochim Biophys Acta. 1614(2):156–164.
  • Chandra A, Aggarwal G, Manchanda S, Narula A. 2019. Development of topical gel of methotrexate incorporated ethosomes and salicylic acid for the Treatment of Psoriasis. Pharm Nanotechnol. 7(5):362–374.
  • Chen X, Peng LH, Shan YH, Li N, Wei W, Yu L, Li QM, Liang WQ, Gao JQ. 2013. Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery. Int J Pharm. 447(1–2):171–181.
  • Chen Z, Li B, Liu T, Wang X, Zhu Y, Wang L, Wang X, Niu X, Xiao Y, Sun Q. 2017. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers. Eur J Pharm Sci. 99:240–245.
  • Chessa M, Caddeo C, Valenti D, Manconi M, Sinico C, Fadda A. 2011. Effect of penetration enhancer containing vesicles on the percutaneous delivery of quercetin through new born pig skin. Pharmaceutics. 3(3):497–509.
  • Chhibber T, Wadhwa S, Chadha P, Sharma G, Katare OP. 2015. Phospholipid structured microemulsion as effective carrier system with potential in methicillin sensitive Staphylococcus aureus (MSSA) involved burn wound infection. J Drug Target. 23(10):943–952.
  • Choi M, Maibach H. 2005. Elastic vesicles as topical/transdermal drug delivery systems. Int J Cosmet Sci. 27(4):211–221.
  • Clinicaltrials 2021. [accessed July 9]. www.clinicaltrials.gov.
  • Cosco D, Celia C, Cilurzo F, Trapasso E, Paolino D. 2008. Colloidal carriers for the enhanced delivery through the skin. Expert Opin Drug Deliv. 5(7):737–755.
  • Danielsson I, Lindman B. 1981. The definition of microemulsion. Colloid Surf. 3(4):391–392.
  • Date A, Patravale V. 2007. Microemulsions: applications in transdermal and dermal delivery. Crit Rev Ther Drug Carrier Syst. 24(6):547–596.
  • Değim Z, Çelebi N, Alemdaroğlu C, Deveci M, Öztürk S, Özoğul C. 2011. Evaluation of chitosan gel containing liposome-loaded epidermal growth factor on burn wound healing. Int Wound J. 8(4):343–354.
  • Deshmukh R, Gawale S, Bhagwat M, Ahire P, Derle N. 2016. A review on: liposomes. World J Pharm Pharm Sci. 5:506–517.
  • Dharashivkar SS, Sahasrabuddhe SH, Saoji AN. 2015. Niosomally encapsulated silver sulfadiazine gel for burn treatment. J Microencapsul. 32(2):137–142.
  • Dragicevic-Curic N, Winter S, Krajisnik D, Stupar M, Milic J, Graefe S, Fahr A. 2010. Stability evaluation of temoporfin-loaded liposomal gels for topical application. J Liposome Res. 20(1):38–48.
  • Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T. 2011. Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J Drug Deliv. 2011:418316–418319.
  • Dubey V, Mishra D, Jain NK. 2007. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm. 67(2):398–405.
  • Duman G, Aslan I, Özer AY, İnanç I, Taralp A. 2014. Liposome, gel and lipogelosome formulations containing sodium hyaluronate. J Liposome Res. 24(4):259–269.
  • El-Aasser M, Sudol E. 2004. Miniemulsions: overview of research and applications. JCT Res. 1(1):21–31.
  • El-Badry M, Fetih G, Shakeel F. 2014. Comparative topical delivery of antifungal drug croconazole using liposome and micro-emulsion-based gel formulations. Drug Deliv. 21(1):34–43.
  • El-Gogary RI, Ragai MH, Moftah N, Nasr M. 2021. Oleuropein as a novel topical antipsoriatic nutraceutical: formulation in microemulsion nanocarrier and exploratory clinical appraisal. Expert Opin Drug Deliv. 18(10):1523–1532.
  • El-Kayal M, Nasr M, Elkheshen S, Mortada N. 2019. Colloidal (-)-epigallocatechin-3-gallate vesicular systems for prevention and treatment of skin cancer: a comprehensive experimental study with preclinical investigation. Eur J Pharm Sci. 137:104972.
  • EL Kayal M, Nasr M, Mortada N, Elkeshen S. 2020. Optimization of the colloidal properties of different vesicular systems aiming to encapsulate (-)-epigallocatechin-3-gallate. Farmacia 68(1):14–97.
  • El Maghraby G. 2012. Microemulsions as transdermal drug delivery systems. Curr Nanosci. 8(4):504–511.
  • El Maghraby G, Williams A, Barry B. 2000. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm. 196(1):63–74.
  • El Maghraby G, Williams A, Barry B. 2004. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm. 276(1–2):143–161.
  • Elosaily GH, Salem HA, Hassan AM, Maxwell S, Ibrahim ZA. 2014. Formulation, in vitro and in vivo evaluation of nystatin topical gel. J Am Sci. 10:75–85.
  • Elsayed M, Abdallah O, Naggar V, Khalafallah N. 2007. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm. 332:1–17.
  • El-Zaafarany G, Awad G, Holayel S, Mortada N. 2010. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 397(1–2):164–172.
  • El-Zaafarany G, Soliman M, Mansour S, Awad G. 2016. Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: in vitro and rat in vivo studies. Int J Pharm. 503(1–2):127–140.
  • El-Zaafarany G, Soliman M, Mansour S, Cespi M, Palmieri G, Illum L, Casettari L, Awad G. 2018. A tailored thermosensitive PLGA-PEG-PLGA/Emulsomes composite for enhanced oxcarbazepine brain delivery via the nasal route. Pharmaceutics. 10(4):217.
  • El-Zaafarany GM, Abdel-Aziz RTA, Montaser MHA, Nasr M. 2021. Coenzyme Q10 phospholipidic vesicular formulations for treatment of androgenic alopecia: ex vivo permeation and clinical appraisal. Expert Opin Drug Deliv. 18(10):1513–1522.
  • Fadel M, Kassab K, Samy N, Abdelfadeel D, Yassin G, Nasr M. 2020. Nanovesicular photodynamic clinical treatment of resistant plantar warts. Curr Drug Deliv. 17(5):396–405.
  • Fadel M, Samy N, Nasr M, Alyoussef AA. 2017. Topical colloidal indocyanine green-mediated photodynamic therapy for treatment of basal cell carcinoma. Pharm Dev Technol. 22(4):545–550.
  • Fang JY, Yu SY, Wu PC, Huang YB, Tsai YH. 2001. In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm. 215(1–2):91–99.
  • Fang Y, Tsai Y, Wu P, Huang Y. 2008. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int J Pharm. 356(1–2):144–152.
  • Fathi-Azarbayjani A, Ng KX, Chan YW. Chan Sy 2015. Lipid vesicles for the skin delivery of diclofenac: cerosomes vs. other lipid suspensions. Adv Pharm Bull. 5:25–33.
  • Foldvari M, Gesztes A, Mezei M. 1990. Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. J Microencapsul. 7(4):479–489.
  • Fytianos G, Rahdar A, Kyzas GZ. 2020. Nanomaterials in cosmetics: recent updates. Nanomaterials. 10(5):979.
  • Gaba B, Fazil M, Khan S, Ali A, Baboota S, Ali J. 2015. Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride. Bull Fac Pharm Cairo Univ. 53(2):147–159.
  • Garg V, Singh H, Bhatia A, Raza K, Singh S, Singh B, Beg S. 2017. Systematic development of transethosomal gel system of piroxicam: formulation optimization, in vitro evaluation, and ex vivo assessment. AAPS PharmSciTech. 18(1):58–71.
  • Garg V, Singh H, Bimbrawh S, Singh S, Gulati M, Vaidya Y, Kaur P. 2017. Ethosomes and transfersomes: principles, perspectives and practices. Curr Drug Deliv. 14(5):613–633.
  • Gasco M. 1993. Method for producing solid lipid microspheres having anarrow size distribution, US Patent 5 250 236.
  • Germain M, Caputo F, Metcalfe S, Tosi G, Spring K, Aslund AKO, Pottier A, Schiffelers R, Ceccaldi A, Schmid R. 2020. Delivering the power of nanomedicine to patients today. J Control Release. 326:164–171.
  • Geusens B, Strobbe T, Bracke S, Dynoodt P, Sanders N, Van Gele M, Lambert J. 2011. Lipid-mediated gene delivery to the skin. Eur J Pharm Sci. 43(4):199–211.
  • Giri T, Pramanik K, Barman T, Maity S. 2017. Nano-encapsulation of dietary phytoconstituent capsaicin on emulsome: evaluation of anticancer activity through the measurement of liver oxidative stress in rats. Anticancer Agents Med Chem. 17(12):1669–1678.
  • Godin B, Touitou E, Rubinstein E, Athamna A, Athamna M. 2005. A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. J Antimicrob Chemother. 55(6):989–994.
  • Goindi S, Dhatt B, Kaur A. 2014. Ethosomes-based topical delivery system of antihistaminic drug for treatment of skin allergies. J Microencapsul. 31(7):716–724.
  • Goindi S, Kumar G, Kumar N, Kaur A. 2013. Development of novel elastic vesicle-based topical formulation of cetirizine dihydrochloride for treatment of atopic dermatitis. AAPS PharmSciTech. 14(4):1284–1293.
  • Goyal G, Garg T, Malik B, Chauhan G, Rath G, Goyal AK. 2015. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. 22(8):1027–1042.
  • Gu Q, You BM, Yang DS, Pan YH, Shu W, Liu JY. 2015. Development of Tripterygium glycosides nano-carries based on “nanoemulsion-gels” and its pharmacodynamics. Zhong Zhong Yao ZaZhi. 40:73–78.
  • Gupta A, Singh S, Niranjan GK, Webster TJ. 2015. Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity. Int J Nanomedicine. 10:171–182.
  • Gupta R, Gupta M, Mangal S, Agrawal U, Vyas S. 2016. Capsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapy. Artif Cells Nanomed Biotechnol. 44(3):825–834.
  • Harde H, Agrawal AK, Katariya M, Kale D, Jain S. 2015. Development of a topical adapalene-solid lipid nanoparticle loaded gel with enhanced efficacy and improved skin tolerability. RSC Adv. 5(55):43917–43929.
  • Harwansh RK, Mukherjee PK, Bahadur S, Biswas R. 2015. Enhanced permeability of ferulic acid loaded nanoemulsion based gel through skin against UVA mediated oxidative stress. Life Sci. 141:202–211.
  • Harwansh RK, Mukherjee PK, Kar A, Bahadur S, Al-Dhabi NA, Duraipandiyan V. 2016. Enhancement of photoprotection potential of catechin loaded nanoemulsion gel against UVA induced oxidative stress. J Photochem Photobiol B. 160:318–329.
  • Hatem S, El Hoffy NM, Elezaby RS, Nasr M, Kamel AO, Elkheshen SA. 2020. Background and different treatment modalities for melasma: conventional and nanotechnology-based approaches. J Drug Deliv Sci Technol. 60:101984.
  • Hatem S, Nasr M, Elkheshen SA, Geneidi AS. 2018. Recent advances in antioxidant cosmeceutical topical delivery. Curr Drug Deliv. 15(7):953–964.
  • Hatem S, Nasr M, Moftah NH, Ragai MH, Geneidi AS, Elkheshen SA. 2018a. Melatonin vitamin C-based nanovesicles for treatment of androgenic alopecia: design, characterization and clinical appraisal. Eur J Pharm Sci. 122:246–253.
  • Hatem S, Nasr M, Moftah NH, Ragai MH, Geneidi AS, Elkheshen SA. 2018b. Clinical cosmeceutical repurposing of melatonin in androgenic alopecia using nanostructured lipid carriers prepared with antioxidant oils. Expert Opin Drug Deliv. 15(10):927–935.
  • He R, Cui D, Gao F. 2009. Preparation of fluorescence ethosomes based on quantum dots and their skin scar penetration properties. Mater Lett. 63(20):1662–1664.
  • Honeywell-Nguyen P, Wouter Groenink H, Graaff A, Bouwstra J. 2003. The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. J Control Rel. 90(2):243–255.
  • Honeywell-Nguyen PL, Bouwstra JA. 2005. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol. 2(1):67–74.
  • Honeywell-Nguyen PL, Frederik PM, Bomans PH, Junginger HE, Bouwstra JA. 2002. Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: characterization and in vitro transport studies. Pharm Res. 19(7):991–997.
  • Hu C, Rhodes D. 1999. Proniosomes: a novel drug carrier preparation. Int J Pharm. 185(1):23–35.
  • Hua S. 2015. Lipid-based nano-delivery systems for skin delivery of drugs and bioactives. Front Pharmacol. 6:219.
  • Hussain A, Samad A, Ramzan M, Ahsan MN, Rehman Z, Ahmad FJ. 2014. Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation. Drug Deliv. 7:1–15.
  • Hussain A, Samad A, Singh SK, Ahsan MN, Haque MW, Faruk A, Ahmed FJ. 2016. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Drug Deliv. 23(2):642–647.
  • Ismail A, Nasr M, Sammour O. 2020. Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: improved pharmacokinetic/pharmacodynamic properties. Int J Pharm. 583:119402.
  • Iwaszkiewicz KS, Hua S. 2014. Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund’s Adjuvant rodent model of acute inflammatory pain. Pain Physician. 17(6):E719–735.
  • Jain S, Jain P, Umamaheshwari R, Jain N. 2003. Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm. 29(9):1013–1026.
  • Jain S, Tiwary A, Sapra B, Jain N. 2007. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech. 8(4):E111.
  • Jung SH, Cho YS, Jun SS, Koo JS, Cheon HG, Shin BC. 2011. Topical application of liposomal cobalamin hydrogel for atopic dermatitis therapy. Pharmazie. 66(6):430–435.
  • Junginger HE, Hofland HEJ, Bouwstra JA. 1991. Liposomes and niosomes interaction with human skin. Cosmet Toiletries. 106:45–50.
  • Kalariya M, Padhi BK, Chougule M, Misra A. 2005. Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: formulation and clinical implications. Indian J Exp Biol. 43(3):233–240.
  • Kassem MA, Esmat S, Bendas ER, El-Komy MH. 2006. Efficacy of topical griseofulvin in treatment of tinea corporis. Mycoses. 49(3):232–235.
  • Kaur A, Katiyar SS, Kushwah V, Jain S. 2017. Nanoemulsion loaded gel for topical co-delivery of clobitasol propionate and calcipotriol in psoriasis. Nanomedicine. 13(4):1473–1482.
  • Kaur L, Jain SK, Singh K. 2015. Vitamin E TPGS based nanogel for the skin targeting of high molecular weight anti-fungal drug: development and in vitro and in vivo assessment. RSC Adv. 5(66):53671–53686.
  • Kausar H, Mujeeb M, Ahad A, Moolakkadath T, Aqil M, Ahmad A, Akhter M. 2019. Optimization of ethosomes for topical thymoquinone delivery for the treatment of skin acne. J Drug Deliv Sci Technol. 49:177–187.
  • Khallaf RA, Salem HF, Abdelbary A. 2016. 5-fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment. Drug Deliv. 23(9):3452–3460.
  • Kim Y, Ludovice P, Prausnitz M. 2007. Transdermal delivery enhanced by magainin pore-forming peptide. J Control Release. 122(3):375–383.
  • Kirjavainen M, Urtti A, Jääskeläinen I, Suhonen T, Paronen P, Valjakka-Koskela R, Kiesvaara J, Mönkkönen J. 1996. Interaction of liposomes with human skin in vitro–the influence of lipid composition and structure. J Biochim Biophys Acta. 1304(3):179–189.
  • Kirjavainen M, Urtti A, Valjakka-Koskela R, Kiesvaara J, Mönkkönen J. 1999. Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci. 7(4):279–286.
  • Korkm E, Gokce EH, Ozer O. 2013. Development and evaluation of coenzyme Q10 loaded solid lipid nanoparticle hydrogel for enhanced dermal delivery. Acta Pharm. 63(4):517–529.
  • Kumar A, Pathak K, Bali V. 2012. Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents. Drug Discov Today. 17(21–22):1233–1241.
  • Lakshmi PK, Devi GS, Bhaskaran S, Sacchidanand S. 2007. Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies. Indian J Dermatol Venereol Leprol. 73(3):157–161.
  • Laouini A, Charcosset C, Fessi H, Holdich R, Vladisavljević G. 2013. Preparation of liposomes: a novel application of microengineered membranes-from laboratory scale to large scale. Colloids Surf B Biointerfaces. 112:272–278.
  • Lew BL, Cho Y, Kim J, Sim WY, Kim NI. 2006. Ceramides and cell signaling molecules in psoriatic epidermis: reduced levels of ceramides, PKC-alpha, and JNK. J Korean Med Sci. 21(1):95–99.
  • Li G, Fan C, Li X, Fan Y, Wang X, Li M, Liu Y. 2012. Preparation and in vitro evaluation of tacrolimus-loaded ethosomes. Scientific World J. 2012:1–6.
  • Li S, Qiu Y, Zhang S, Gao Y. 2012. Enhanced transdermal delivery of 18β-glycyrrhetic acid via elastic vesicles: in vitro and in vivo evaluation. Drug Dev Ind Pharm. 38(7):855–865.
  • Lovelyn C, Attama A. 2011. Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol. 02(05):626–639.
  • Madan JR, Khude PA, Dua K. 2014. Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery. Int J Pharm Investig. 4(2):60–64.
  • Mahmood S, Chatterjee B, Mandal U. 2021. Pharmacokinetic evaluation of the synergistic effect of raloxifene loaded transfersomes for transdermal delivery. J Drug Deliv Sci Technol. 63:102545.
  • Manca M, Mir-Palomo S, Caddeo C, Nacher A, Díez-Sales O, Peris J, Pedraz J, Fadda A, Manconi M. 2019. Sorbitol-penetration enhancer containing vesicles loaded with baicalin for the protection and regeneration of skin injured by oxidative stress and UV radiation. Int J Pharm. 555:175–183.
  • Manconi M, Caddeo C, Sinico C, Valenti D, Mostallino M, Lampis S, Monduzzi M, Fadda A. 2012. Penetration enhancer-containing vesicles: composition dependence of structural features and skin penetration ability. Eur J Pharm Biopharm. 82(2):352–359.
  • Manconi M, Manca ML, Caddeo C, Valenti D, Cencetti C, Diez-Sales O, Nacher A, Mir-Palomo S, Terencio MC, Demurtas D, et al. 2018. Nanodesign of new self-assembling core-shell gellan-transfersomes loading baicalin and in vivo evaluation of repair response in skin. Nanomedicine. 14(2):569–579.
  • Manconi M, Pendás J, Ledón N, Moreira T, Sinico C, Saso L, Fadda AM. 2009. Phycocyanin liposomes for topical anti-inflammatory activity: in vitro in vivo studies. J Pharm Pharmacol. 61(4):423–430.
  • Manconi M, Sinico C, Caddeo C, Vila A, Valenti D, Fadda A. 2011. Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm. 412(1–2):37–46.
  • Manosroi A, Chutoprapat R, Sato Y, Miyamoto K, Hsueh K, Abe M, Manosroi W, Manosroi J. 2011. Antioxidant activities and skin hydration effects of rice bran bioactive compounds entrapped in niosomes. J Nanosci Nanotechnol. 11(3):2269–2277.
  • Manosroi A, Jantrawut P, Akihisa T, Manosroi W, Manosroi J. 2011. In vitro and in vivo skin anti-aging evaluation of gel containing niosomes loaded with a semi-purified fraction containing gallic acid from Terminalia chebula galls. Pharm Biol. 49(11):1190–1203.
  • Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, Abe M. 2003. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B Biointerfaces. 30(1–2):129–138.
  • Mason T, Wilking J, Meleson K, Chang C, Graves S. 2006. Nanoemulsions: formation, structure, and physical properties. J Phys Condens Matter. 18 (41):R635–R666.
  • Matei AM, Caruntu C, Tampa M, Georgescu SR, Matei C, Constantin MM, Constantin TV, Calina D, Ciubotaru DA, Badarau IA, et al. 2021. Applications of nanosized-lipid-based drug delivery systems in wound care. Appl Sci. 11(11):4915.
  • McClements DJ. 2012. Nanoemulsions versus microemulsions: terminology, differences and similarities. Soft Matter. 8(6):1719–1729.
  • Menezes A, Campos P, Euletério C, Simões S, Praça F, Bentley M, Ascenso A. 2016. Development and characterization of novel 1-(1-Naphthyl)piperazine-loaded lipid vesicles for prevention of UV-induced skin inflammation. Eur J Pharm Biopharm. 104:101–109.
  • Mohamed MA, Nasr M, Elkhatib WF, Eltayeb WN. 2018. In vitro evaluation of antimicrobial activity and cytotoxicity of different nanobiotics targeting multidrug resistant and biofilm forming Staphylococci. Biomed Res Int. 2018:7658238.
  • Mohammed M, Makky A, Teaima M, Abdellatif M, Hamzawy M, Khalil M. 2015. Transdermal delivery of vancomycin hydrochloride using combination of nano-ethosomes and iontophoresis: in vitro and in vivo study. Drug Deliv. 2:1–7.
  • Moolakkadath T, Aqil M, Ahad A, Imam S, Praveen A, Sultana Y, Mujeeb M, Iqbal Z. 2019. Fisetin loaded binary ethosomes for management of skin cancer by dermal application on UV exposed mice. Int J Pharm. 560:78–91.
  • Morrow D, McCarron P, Woolfson A, Donnelly R. 2007. Innovative strategies for enhancing topical and transdermal drug delivery. Open Drug Deliv J. 1(1):36–59.
  • Motta S, Monti M, Sesana S, Mellesi L, Ghidoni R, Caputo R. 1994. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol. 130(4):452–456.
  • Muller RH, Mader K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm. 50(1):161–177.
  • Muller RH, Mehnert W, Lucks JS, Schwarz C, Zur Muhlen A, Weyhers H, Freitas C, Ruhl D. 1995. Solid lipid nanoparticles (SLN) – an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm. 41:62–69.
  • Muller RH, Radtke M, Wissing SA. 2002a. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 54:S131–S155.
  • Muller RH, Radtke M, Wissing SA. 2002b. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 242(1-2):121–128.
  • Mura S, Manconi M, Fadda A, Sala M, Perricci J, Pini E, Sinico C. 2013. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy. Pharm Dev Technol. 18(6):1339–1345.
  • Mura S, Manconi M, Sinico C, Valenti D, Fadda A. 2009. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm. 380(1–2):72–79.
  • Nagaich U, Gulati N. 2016. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Drug Deliv Transl Res. 6(3):289–298.
  • Nasr M. 2016. Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery. Drug Deliv. 23(4):1444–1452.
  • Nasr M, Abdel-Hamid S. 2016. Optimizing the dermal accumulation of a tazarotene microemulsion using skin deposition modeling. Drug Dev Ind Pharm. 42(4):636–643.
  • Nasr M, Abdel-Hamid S, Moftah NH, Fadel M, Alyoussef AA. 2017. Jojoba oil soft colloidal nanocarrier of a synthetic retinoid: preparation, characterization and clinical efficacy in psoriatic patients. Curr Drug Deliv. 14(3):426–432.
  • Nasr M, Al-Karaki R. 2020. Nanotechnological innovations enhancing the topical therapeutic efficacy of quercetin: a succinct review. Curr Drug Deliv. 17(4):270–278.
  • Nasr M, Mansour S, Mortada ND, El Shamy AA. 2008b. Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation. AAPS PharmSciTech. 9(1):154–162.
  • Nasr M, Mansour S, Mortada ND, El Shamy AA. 2008a. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul. 25(7):499–512.
  • Nasr S, Rady M, Gomaa I, Syrovets T, Simmet T, Fayad W, Abdel-Kader M. 2019. Ethosomes and lipid-coated chitosan nanocarriers for skin delivery of a chlorophyll derivative: a potential treatment of squamous cell carcinoma by photodynamic therapy. Int J Pharm. 568:118528.
  • Nastiti C, Ponto T, Abd E, Grice J, Benson H, Roberts M. 2017. Topical nano and microemulsions for skin delivery. Pharmaceutics. 9(4):37–25.
  • Negi P, Aggarwal M, Sharma G, Rathore C, Sharma G, Singh B, Katare OP. 2017. Niosome-based hydrogel of resveratrol for topical applications: an effective therapy for pain related disorder(s). Biomed Pharmacother. 88:480–487.
  • Oh E, Jin S, Kim J, Park J, Park Y, Kim C. 2011. Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy. Eur J Pharm Sci. 44(1–2):149–157.
  • Pal A, Gupta S, Jaiswal A, Dube A, Vyas S. 2012. Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis. J Liposome Res. 22(1):62–71.
  • Paliwal R, Paliwal S, Mishra N, Mehta A, Vyas S. 2009. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate. Int J Pharm. 380(1–2):181–188.
  • Paliwal S, Tilak A, Sharma J, Dave V, Sharma S, Yadav R, Patel S, Verma K, Tak K. 2019. Flurbiprofen loaded ethosomes - transdermal delivery of anti-inflammatory effect in rat model. Lipids Health Dis. 18(1):133–148.
  • Paolino D, Celia C, Trapasso E, Cilurzo F, Fresta M. 2012. Paclitaxel-loaded ethosomes®: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses. Eur J Pharm Biopharm. 81(1):102–112.
  • Patel D, Dasgupta S, Dey S, Ramani YR, Ray S, Mazumder B. 2012. Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization, and in vivo evaluation. Sci Pharm. 80(3):749–764.
  • Patel MR, Patel RB, Parikh JR, Patel BG. 2016. Novel isotretinoin microemulsion based gel for targeted topical therapy of acne: formulation consideration, skin retention and skin irritation studies. Appl Nanosci. 6(4):539–553.
  • Patel PR, Patel HH, Baria HA. 2009. Formulation and evaluation of liposomes of ketoconazole. Int J Drug Deliv Technol. 1:16–23.
  • Patel VB, Misra A, Marfatia YS. 2000. Topical liposomal gel of tretinoin for the treatment of acne: research and clinical implications. Pharm Dev Technol. 5(4):455–464.
  • Patel VB, Misra AN, Marfatia YS. 2001. Preparation and comparative clinical evaluation of liposomal gel of benzoyl peroxide for acne. Drug Dev Ind Pharm. 27(8):863–869.
  • Pirvu C, Hlevca C, Ortan A, Prisada R. 2010. Elastic vesicles as drugs carriers through the skin. Farmacia. 58:128–135.
  • Prasad S, Mukhopadhyay A, Kubavat A, Kelkar A, Modi A, Swarnkar B, Bajaj B, Vedamurthy M, Sheikh S, Mittal R. 2012. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial. Indian J Dermatol Venereol Leprol. 78:459–467.
  • Priprem A, Janpim K, Nualkaew S, Mahakunakorn P. 2016. Topical niosome gel of zingiber cassumunar roxb. Extract for anti-inflammatory activity enhanced skin permeation and stability of compound D. AAPS PharmSciTech. 17(3):631–639.
  • Puglia C, Trombetta D, Venuti V, Saija A, Bonina F. 2004. Evaluation of in-vivo topical anti-inflammatory activity of indometacin from liposomal vesicles . J Pharm Pharmacol. 56(10):1225–1232.
  • Qidwai A, Khan S, Md S, Fazil M, Baboota S, Narang JK, Ali J. 2016. Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma. Drug Deliv. 23(4):1476–1485.
  • Rahimpour Y, Kouhsoltani M, Hamishehkar H. 2015. Proniosomes in transdermal drug delivery. Curr Pharm Des. 21(20):2883–2891.
  • Rahman M, Beg S, Akhter S. 2019. Conventional formulations, challenges, and nanomedicines in infective and non-infective skin diseases therapy. Recent Pat Antiinfect Drug Discov. 14(1):5–6.
  • Rajera R, Nagpal K, Singh SK, Mishra DN. 2011. Niosomes: a controlled and novel drug delivery system. Biol Pharm Bull. 34(7):945–953.
  • Rajinikanth PS, Chellian J. 2016. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil. Int J Nanomedicine. 11:5067–5077.
  • Raza K, Katare O, Setia A, Bhatia A, Singh B. 2013. Improved therapeutic performance of dithranol against psoriasis employing systematically optimized nanoemulsomes. J Microencapsul. 30(3):225–236.
  • Raza K, Singh B, Lohan S, Sharma G, Negi P, Yachha Y, Katare OP. 2013. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. Int J Pharm. 456(1):65–72.
  • Razavi H, Janfaza S. 2015. Ethosome: a nanocarrier for transdermal drug delivery. J Paramed Sci. 6:38–43.
  • Reimer K, Vogt PM, Broegmann B, Hauser J, Rossbach O, Kramer A, Rudolph P, Bosse B, Schreier H, Fleischer W. 2000. An innovative topical drug formulation for wound healing and infection treatment: in vitro and in vivo investigations of a povidone-iodine liposome hydrogel. Dermatology. 201(3):235–241.
  • Roberts M, Mohammed Y, Pastore M, Namjoshi S, Yousef S, Alinaghi A, Haridass I, Abd E, Leite-Silva V, Benson H, et al. 2017. Topical and cutaneous delivery using nanosystems. J Control Release. 247:86–105.
  • Sachan R, Parashar T, Soniya Singh V, Singh G, Tyagi S, Patel C, Gupta A. 2013. Drug carrier Transfersomes: a novel tool for transdermal drug delivery system. Int J Res Dev Pharm Life Sci. 2:309–316.
  • Sah AK, Jain SK, Pandey RS. 2011. Microemulsion based hydrogel formulation of methoxsalen for the effective treatment of psoriasis. Asian J Pharm Clin Res. 4:140–145.
  • Sala M, Diab R, Elaissari A, Fessi H. 2018. Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications. Int J Pharm. 535(1–2):1–17.
  • Sankar V, Ruckmani K, Durga S, Jailani S. 2010. Proniosomes as drug carriers. Pak J Pharm Sci. 23(1):103–107.
  • Sanna V, Gavini E, Cossu M, Rassu G, Giunchedi P. 2007. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. J Pharm Pharmacol. 59(8):1057–1064.
  • Sarfaraz Alam M, Ali MS, Zakir F, Alam N, Intakhab Alam M, Ahmad F, Siddiqui MR, Ali MD, Ansari MS, Ahmad S, et al. 2016. Enhancement of anti-dermatitis potential of clobetasol propionate by DHA [Docosahexaenoic acid] rich algal oil nanoemulsion gel. Iran J Pharm Res. 15(1):35–52.
  • Schreier H, Bouwstra J. 1994. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control. Release. 30(1):1–15.
  • Shaaban M, Nasr M, Tawfik AA, Fadel M, Sammour O. 2021. Bergamot oil as an integral component of nanostructured lipid carriers and a photosensitizer for photodynamic treatment of vitiligo: characterization and clinical experimentation. Expert Opin Drug Deliv. 18(1):139–150.
  • Shah H, Nair A, Jigar Shah J, Jacob S, Bharadia P, Haroun M. 2021. Proniosomal vesicles as an effective strategy to optimize naproxen transdermal delivery. J Drug Deliv Sci Technol. 63:102479.
  • Shah KA, Date AA, Joshi MD, Patravale VB. 2007. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm. 345(1–2):163–171.
  • Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S. 2008. Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnol. 6(1):8.
  • Shen L, Zhang Y, Wang Q, Xu L, Feng N. 2014. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm. 460(1–2):280–288.
  • Shinde U, Pokharkar S, Modani S. 2012. Design and evaluation of microemulsion gel system of nadifloxacin. Indian J Pharm Sci. 74(3):237–247.
  • Shirsand SB, Para MS, Nagendrakumar D, Kanani KM, Keerthy D. 2012. Formulation and evaluation of ketoconazole niosomal gel drug delivery system. Int J Pharm Investig. 2(4):201–207.
  • Shrotriya SN, Ranpise NS, Vidhate BV. 2017. Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis. Drug Deliv Transl Res. 7(1):37–52.
  • Sinha P, Srivastava S, Mishra N, Singh DK, Luqman S, Chanda D, Yadav NP. 2016. Development, optimization, and characterization of a novel tea tree oil nanogel using response surface methodology. Drug Dev Ind Pharm. 42(9):1434–1445.
  • Solans C, Solé I. 2012. Nano-emulsions: formation by low-energy methods. Curr Opin Colloid Int Sci. 17(5):246–254.
  • Sonawane R, Harde H, Katariya M, Agrawal S, Jain S. 2014. Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis. Expert Opin Drug Deliv. 11(12):1833–1847.
  • Song C, Balakrishnan P, Shim C, Chung S, Chong S, Kim D. 2012. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces. 92:299–304.
  • Song Y, Kim C. 2006. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials. 27(2):271–280.
  • Sonneville-Aubrun O, Simonnet J, L’Alloret F. 2004. Nanoemulsions: a new vehicle for skincare products. Adv Colloid Interface Sci. 108–109:145–149.
  • Souto EB, Muller RH. 2008. Cosmetic features and applications of lipid nanoparticles (SLN, NLC). Int J Cosmet Sci. 30(3):157–165.
  • Sudhakar B, Varma JN, Murthy KV. 2014. Formulation, characterization and ex vivo studies of terbinafine HCl liposomes for cutaneous delivery. Curr Drug Deliv. 11(4):521–530.
  • Tadros T, Izquierdo P, Esquena J, Solans C. 2004. Formation and stability of nanoemulsions. Adv Colloid Interface Sci. 108–109:303–318.
  • Thomas L, Zakir F, Mirza MA, Anwer MK, Ahmad FJ, Iqbal Z. 2017. Development of curcumin loaded chitosan polymer based nanoemulsion gel: in vitro, ex vivo evaluation and in vivo wound healing studies. Int J Biol Macromol. 101:569–579.
  • Torchilin VP. 2005. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 4(2):145–160.
  • Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. 2000. Ethosomes–novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Rel. 65(3):403–418.
  • Touitou E, Godin B. 2007. Ethosomes for skin delivery. J Drug Deliv Sci Technol. 17(5):303–308.
  • Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F. 2001. Intracellular delivery mediated by an ethosomal carrier. Biomaterials. 22(22):3053–3059.
  • Uchegbu IF, Vyas SP. 1998. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 172(1–2):33–70.
  • Ucisik M, Sleytr U, Schuster B. 2015. Emulsomes meet S-layer proteins: an emerging targeted drug delivery system. Curr Pharm Biotechnol. 16(4):392–405.
  • Uprit S, Sahu RK, Roy A, Pare A. 2013. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharm J. 21(4):379–385.
  • Vaghasiya H, Kumar A, Sawant K. 2013. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. Eur J Pharm Sci. 49(2):311–322.
  • Verma S, Utreja P. 2018. Transethosomes of econazole nitrate for transdermal delivery: development, In-vitro characterization, and ex-vivo assessment. Pharm Nanotechnol. 6(3):171–179.
  • Vora B, Khopade A, Jain N. 1998. Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release. 54(2):149–165.
  • Xie J, Ji Y, Xue W, Ma D, Hu Y. 2018. Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery. Colloids Surf B Biointerfaces. 172:323–329.
  • Xu P, Tan G, Zhou J, He J, Lawson LB, McPherson GL, John VT. 2009. Undulating tubular liposomes through incorporation of a synthetic skin ceramide into phospholipid bilayers. Langmuir. 25(18):10422–10425.
  • Yan Y, Zhang H, Sun J, Wang P, Dong K, Dong Y, Xin J. 2016. Enhanced transdermal delivery of sinomenine hydrochloride by ethosomes for anti-inflammatory treatment. J Drug Deliv Sci Technol. 36:201–207.
  • Yang L, Wu L, Wu D, Shi D, Wang T, Zhu X. 2017. Mechanism of transdermal permeation promotion of lipophilic drugs by ethosomes. Int J Nanomedicine. 12:3357–3364.
  • Yu M, Ma H, Lei M, Li N, Tan F. 2014. In vitro/in vivo characterization of nanoemulsion formulation of metronidazole with improved skin targeting and anti-rosacea properties. Eur J Pharm Biopharm. 88(1):92–103.
  • Yu X, Du L, Li Y, Fu G, Jin Y. 2015. Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel. Biomed Pharmacother. 73:6–11.
  • Yutani R, Teraoka S, Kitagawa S. 2015. Microemulsion using polyoxyethylene sorbitan trioleate and its usage for skin delivery of resveratrol to protect skin against UV-induced damage. Chem Pharm Bull (Tokyo). 63(9):741–745.
  • Zhai Y, Xu R, Wang Y, Liu J, Wang Z, Zhai G. 2015. Ethosomes for skin delivery of ropivacaine: preparation, characterization and ex vivo penetration properties. J Liposome Res. 27:1–9.
  • Zhang Y, Shen L, Wu Z, Zhao J, Feng NP. 2014. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy. Int J Pharm. 471(1–2):449–452.
  • Zhou X, Chen Z. 2015. Preparation and performance evaluation of emulsomes as a drug delivery system for silybin. Arch Pharm Res. 38(12):2193–2200.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.